Referral rate to oncologists and its variation by hospital for colorectal cancer patients

Annals of Surgical Oncology

Volumn 19, Issue 3, 2012, Pages 714-721

  Kreiter, E ^a   Yasui, Y ^a   De Gara, C ^b   White, J ^a   Winget, M ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b 2 590 Edmonton Clinic Health Academy   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CONSULTATION; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; ONCOLOGIST; PATIENT REFERRAL; RECTUM CARCINOMA; ADENOCARCINOMA; CANADA; COLORECTAL TUMOR; ONCOLOGY; PRACTICE GUIDELINE; STATISTICS;

ADENOCARCINOMA; AGED; ALBERTA; COLORECTAL NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; MALE; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION;

EID: 84862245536     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2063-y     Document Type: Article

References (50)

1. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-50.
2. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8. (Pubitemid 20042739)
3. Fisher B, Wolmark N, Rockette H, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst. 1988;80:21-9. (Pubitemid 18076565)
4. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001;358:1291-304.
5. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-40.
6. Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22:1785-96. (Pubitemid 41095168)
7. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644-50.
8. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009; 27:5124-30.
9. Wong RK, Berry S, Spithoff K, et al. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol). 2010;22:265-71.
10. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294:2703-11. (Pubitemid 41770099)
11. Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107:2581-8. (Pubitemid 44845611)
12. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-7. (Pubitemid 32590779)
13. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-300. (Pubitemid 46606406)
14. Cree M, Tonita J, Turner D, et al. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. Clin Colorectal Cancer. 2009;8:141-5.
15. Dobie SA, Warren JL, Matthews B, Schwartz D, Baldwin LM, Billingsley K. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer. 2008;112:789-99.
16. Wirtzfeld DA, Mikula L, Gryfe R, et al. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Can J Surg. 2009;52:92-7.
17. Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, Grann VR. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643-50. (Pubitemid 34575636)
18. Winget M, Hossain S, Yasui Y, Scarfe A. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment. Cancer. 2010;116:4849-56.
19. Sharaf Eldin N, Yasui Y, Scarfe A, Winget M. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada. Clin Oncol. doi:10.1016/j.clon.2011.07.005.
20. Fritz AG, Jack A, Parkin DM, Percy C, Shanmugarathan S, Sobin L, Whelan S. International classification of diseases for oncology (ICD-O), 3rd edn. Geneva: World Health Organization; 2000.
21. Tucker TC, Howe HL, Weir HK. Certification for population-based cancer registries. J Reg Mgmt. 1999;26:24-7.
22. Greene FL, Page D, Fleming I, et al. AJCC cancer staging manual, 6th edn. New York: Springer-Verlag; 2002.
23. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-9.
24. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. (Pubitemid 41587600)
25. Christiansen CL, Morris CN. Improving the statistical approach to health care provider profiling. Ann Intern Med. 1997;127: 764-8. (Pubitemid 27446563)
26. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61. (Pubitemid 19116001)
27. Statistics Canada. Population and dwelling counts, for Canada, provinces and territories, census metropolitan areas and census agglomerations, 2006 and 2001 censuses - 100% data: Alberta. http://www12.statcan.gc.ca/census- recensement/2006/dp-pd/hlt/97-550/Index.cfm?TPL=P1C&Page=RETR&LANG= Eng&T=202&PR=48&S=0&O=D&RPP=50 (2010). Accessed 12 June 2011.
28. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324:709-15.
29. Lima IS, Yasui Y, Scarfe A, Winget M. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer 2011;117:3833-40.
30. Hao Y, Landrine H, Jemal A, et al. Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Commun Health. 2011;65:211-7.
31. Sankaranarayanan J, Watanabe-Galloway S, Sun J, Qiu F, Boilesen EC, Thorson AG. Age and rural residence effects on accessing colorectal cancer treatments: a registry study. Am J Manag Care. 2010;16:265-73.
32. Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J. Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer. 2002;87:585-90.
33. Robertson R, Campbell NC, Smith S, et al. Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer. 2004;90:1479-85. (Pubitemid 38648225)
34. Luo R, Giordano SH, Freeman JL, Zhang D, Goodwin JS. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist. 2006;11: 1025-33. (Pubitemid 44564812)
35. Luo R, Giordano SH, Zhang DD, Freeman J, Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109:975-82. (Pubitemid 46333539)
36. Ong S, Watters JM, Grunfeld E, O'Rourke K. Predictors of referral for adjuvant therapy for colorectal cancer. Can J Surg. 2005;48:225-9. (Pubitemid 40910650)
37. Oliveria SA, Yood MU, Campbell UB, Yood SM, Stang P. Treatment and referral patterns for colorectal cancer. Med Care. 2004;42:901-6. (Pubitemid 39456922)
38. Abraham NS, Gossey JT, Davila JA, Al-Oudat S, Kramer JK. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol. 2006;101:1320-8. (Pubitemid 43830000)
39. Billingsley KG, Morris AM, Dominitz JA, et al. Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg. 2007;142:23-31; discussion 32.
40. Borowski DW, Bradburn DM, Mills SJ, et al. Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg. 2010; 97:1416-30.
41. Karanicolas PJ, Dubois L, Colquhoun PH, Swallow CJ, Walter SD, Guyatt GH. The more the better? The impact of surgeon and hospital volume on in-hospital mortality following colorectal resection. Ann Surg. 2009;249:954-9.
42. Rogers SO Jr, Wolf RE, Zaslavsky AM, Wright WE, Ayanian JZ. Relation of surgeon and hospital volume to processes and outcomes of colorectal cancer surgery. Ann Surg 2006;244:1003-11. (Pubitemid 44808643)
43. van Gijn W, Gooiker GA, Wouters MW, Post PN, Tollenaar RA, van de Velde CJ. Volume and outcome in colorectal cancer surgery. Eur J Surg Oncol 2010;36(Suppl 1):S55-63.
44. Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, McGlynn EA. Who is at greatest risk for receiving poor-quality health care? N Engl J Med. 2006;354:1147-56.
45. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348:2635-45. (Pubitemid 36741592)
46. Arnlind MH, Wettermark B, Nokela M, Hjemdahl P, Rehnberg C, Jonsson EW. Regional variation and adherence to guidelines for drug treatment of asthma. Eur J Clin Pharmacol. 2010;66: 187-98.
47. Kumar A, Fonarow GC, Eagle KA, et al. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry. Crit Pathw Cardiol. 2009;8:104-11.
48. Mulley AG. Improving productivity in the NHS. BMJ. 2010;341: c3965.
49. Right Care, National Health Services. The NHS atlas of variation in healthcare. http://www.rightcare.nhs.uk/atlas/qipp-nhsAtlas-HIGH-261110c.pdf (2010). Accessed 12 June 2011.
50. Neugut AI, Grann VR. Referral to medical oncologists: are there barriers at the gate? J Clin Oncol. 2002;20:1716-8. (Pubitemid 34273257)